darunavir has been researched along with Pregnancy in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (14.71) | 29.6817 |
2010's | 21 (61.76) | 24.3611 |
2020's | 8 (23.53) | 2.80 |
Authors | Studies |
---|---|
Brummel, SS; Chadwick, EG; Huo, Y; Jacobson, DL; Jao, J; Kacanek, D; Kahlert, CR; Patel, K; Powis, KM; Seage, GR; Shiau, S; Sultan-Beyer, L; Williams, PL; Yee, LM; Zash, R | 1 |
Avettand-Fenoel, V; Brunet-Cartier, C; Bui, E; Canestri, A; Chabrol, A; Chambrin, V; Delmas, S; Frange, P; Le Chenadec, J; Mandelbrot, L; Marchand, L; Morlat, P; Paul, C; Peretti, D; Peytavin, G; Sibiude, J; Simon-Toulza, C; Tubiana, R; Warszawski, J | 1 |
Best, BM; Capparelli, EV; Chakhtoura, N; Eke, AC; Kreitchmann, R; Mirochnick, M; Shapiro, DE; Smith, E; Stek, AM; Wang, J | 1 |
Acosta, S; Dunk, C; Kala, S; Serghides, L | 1 |
Al-Majed, AA; Alsaif, NA; Alzaid, A; Bakheit, AH; Darwish, IA; Herqash, RN | 1 |
Best, BM; Burchett, S; Capparelli, EV; Chakhtoura, N; Denson, K; Febo, IL; George, K; Mirochnick, M; Momper, JD; Paul, ME; Rungruengthanakit, K; Scott, GB; Shapiro, DE; Smith, E; Stek, A; Wang, J; Yang, DZ | 1 |
Boix, V; Dash, PK | 1 |
Chen, L; He, G; Jia, Y; Tian, X; Wang, K; Yao, Y | 1 |
Chatelut, E; Delobel, P; Gandia, P; Metsu, D; Toutain, PL | 1 |
Buaben, AO; Burger, DM; Colbers, AP; Freriksen, JJM; Greupink, R; Russel, FGM; Schalkwijk, S | 1 |
Kashuba, A; Pope, R | 1 |
Cetin, I; Dalzero, S; Degli Antoni, A; Floridia, M; Francisci, D; Frisina, V; Liuzzi, G; Maccabruni, A; Masuelli, G; Ravizza, M; Sansone, M; Simonazzi, G; Tamburrini, E; Tassis, B | 1 |
Best, BM; Burger, DM; Capparelli, E; Colbers, A; Cressey, TR; Greupink, R; Karlsson, MO; Mirochnick, M; Moltó, J; Russel, FGM; Schalkwijk, S; Ter Heine, R | 1 |
Avramovic, G; Else, LJ; Jackson, V; Khoo, SH; Kuan, KB; Lambert, JS; Lawler, M; Le Blanc, D; McDonald, G; Murtagh, R; Patel, A; Redmond, N | 1 |
Bicer, C; Brown, K; Crauwels, HM; Osiyemi, O; Zorrilla, C | 1 |
Be, G; Chiesi, S; Lanzafame, M; Lattuada, E; Piacentini, D; Rizzardo, S; Tacconelli, E | 1 |
Bonora, S; Calcagno, A; D'Avolio, A; Di Perri, G; Ghisetti, V; Marinaro, L; Montrucchio, C; Trentini, L | 1 |
Baugh, B; Brown, K; Coate, B; Falcon, R; Kakuda, TN; Mrus, J; Osiyemi, OO; Verboven, P; Wright, R; Yasin, S; Zorrilla, CD | 1 |
Afonina, LIu; Voronin, EE | 1 |
Brochot, A; Hoetelmans, RM; Kakuda, TN; Tomaka, FL; Van De Casteele, T; Vangeneugden, T | 1 |
Belissa, E; Duro, D; Mandelbrot, L; Peytavin, G | 1 |
Burger, D; Colbers, A; Giaquinto, C; Gingelmaier, A; Hawkins, D; Ivanovic, J; Kabeya, K; Moltó, J; Sadiq, ST; Taylor, G; Van der Ende, M; Weizsäcker, K | 1 |
Best, BM; Burchett, SK; Capparelli, EV; Cressey, TR; Kreitchmann, R; Mirochnick, M; Mofenson, LM; Rungruengthanakit, K; Shapiro, D; Smith, E; Stek, A; Wang, J | 1 |
Burger, D; Colbers, A; Greupink, R; Litjens, C; Russel, FG | 1 |
Baugh, B; Brown, K; Crauwels, HM; Hillewaert, V; Kakuda, TN; Osiyemi, OO; Ryan, B; Verboven, P; Yasin, S; Zorrilla, C | 1 |
Galindo Puerto, MJ | 1 |
Cerini, C; Fasan, S; Giacomet, V; Marchetti, G; Meroni, L; Pradella, A; Vanzulli, A; Viganò, A; Zuccotti, GV | 1 |
Abusamra, L; Cahn, P; Cesar, C; Fink, V; Gun, A; Krolewiecki, A; Lattner, J; Patterson, P; Sued, O | 1 |
Cattaneo, D; Cortinovis, M; Maggiolo, F; Ripamonti, D; Suter, F | 1 |
Bollens, D; Castaigne, V; Girard, PM; Meyohas, MC; Morand-Joubert, L; Pacanowski, J; Poirier, JM | 1 |
Portilla, J | 1 |
De Luca, A; Navarra, P; Pinnetti, C; Ragazzoni, E; Tamburrini, E | 1 |
Bellagamba, R; Ivanovic, J; Mazzitelli, L; Narciso, P; Nicastri, E; Signore, F; Tempestilli, M; Tommasi, C; Vallone, C | 1 |
Antoniou, T; Bitnun, A; Brophy, J; Jaworsky, D; Loutfy, MR; Samson, L; Thompson, C; Yudin, MH | 1 |
5 review(s) available for darunavir and Pregnancy
Article | Year |
---|---|
Darunavir: A comprehensive profile.
Topics: Darunavir; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Pregnancy; United States | 2021 |
Darunavir for use in pregnant women with HIV.
Topics: Animals; Darunavir; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious | 2017 |
[Use of darunavir in HIV-infected women during pregnancy].
Topics: Darunavir; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy; Pregnancy Complications, Infectious; Sulfonamides; Treatment Outcome | 2013 |
Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir.
Topics: Age Factors; Anti-HIV Agents; Darunavir; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Pregnancy; Sex Factors; Sulfonamides | 2014 |
[Safety and tolerability of etravirine].
Topics: Animals; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Drug Eruptions; Drug Evaluation, Preclinical; Dyslipidemias; Female; Fetus; Gastrointestinal Diseases; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides | 2009 |
6 trial(s) available for darunavir and Pregnancy
Article | Year |
---|---|
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
Topics: Anti-HIV Agents; Darunavir; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Ritonavir; Treatment Outcome; Viral Load | 2023 |
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
Topics: Anti-HIV Agents; Child; Cobicistat; Darunavir; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placenta; Postpartum Period; Pregnancy; Prospective Studies | 2021 |
Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen.
Topics: Adult; Cobicistat; Darunavir; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Treatment Outcome | 2019 |
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
Topics: Adolescent; Adult; Darunavir; Drug Administration Schedule; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Sulfonamides; Young Adult | 2014 |
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.
Topics: Adult; Darunavir; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sulfonamides; Treatment Outcome; Viral Load; Young Adult | 2015 |
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
Topics: Adolescent; Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Darunavir; Female; HIV Infections; Humans; Plasma; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Tandem Mass Spectrometry; Young Adult | 2016 |
23 other study(ies) available for darunavir and Pregnancy
Article | Year |
---|---|
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Cohort Studies; Darunavir; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Oxazines; Piperazines; Pregnancy; Premature Birth; Pyridones; Quinolones; Raltegravir Potassium; Rilpivirine; Ritonavir; United States | 2022 |
Darunavir Pharmacokinetics With an Increased Dose During Pregnancy.
Topics: Adult; Darunavir; Dose-Response Relationship, Drug; Drug Combinations; Female; HIV; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Statistics as Topic; Young Adult | 2020 |
Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
Topics: Animals; Betacoronavirus; Cells, Cultured; Clinical Trials as Topic; Coculture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Decidua; Disease Models, Animal; Drug Repositioning; Drug Therapy, Combination; Embryo Implantation; Endometrium; Female; HIV Infections; Humans; Lopinavir; Maternal Exposure; Mice; Pandemics; Placentation; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Primary Cell Culture; SARS-CoV-2; Trophoblasts; Vascular Remodeling | 2020 |
Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
Topics: Anti-HIV Agents; Cobicistat; Darunavir; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy | 2021 |
Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Darunavir; Data Mining; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pharmacovigilance; Pregnancy; Pregnancy Complications; United States; United States Food and Drug Administration; Young Adult | 2021 |
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?
Topics: Atazanavir Sulfate; Blood Proteins; Darunavir; Dose-Response Relationship, Drug; Female; Hepatocytes; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy; Protein Binding | 2017 |
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
Topics: Darunavir; Drug Therapy, Combination; Female; Fetus; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Models, Biological; Placenta; Pregnancy; Ritonavir | 2018 |
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Cholesterol; Darunavir; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Triglycerides; Viral Load | 2018 |
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.
Topics: Anti-HIV Agents; Computer Simulation; Darunavir; Dose-Response Relationship, Drug; Female; Gestational Age; HIV Seropositivity; Humans; Models, Theoretical; Population; Pregnancy; Pregnancy Complications, Infectious; Ritonavir | 2019 |
Therapeutic drug monitoring of darunavir/ritonavir in pregnancy.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Treatment Outcome; Viral Load; Young Adult | 2019 |
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report.
Topics: Darunavir; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Pyridones; Viral Load; Young Adult | 2019 |
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Darunavir; Female; HIV Infections; Humans; Infant; Infant, Newborn; Maraviroc; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; RNA, Viral; Sulfonamides; Treatment Failure; Triazoles; Viral Load | 2013 |
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Topics: Biological Transport; Darunavir; Female; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Placenta; Pregnancy; Sulfonamides | 2014 |
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.
Topics: Adolescent; Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Cohort Studies; Darunavir; Female; HIV Infections; Humans; Plasma; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Ritonavir; Sulfonamides; Young Adult | 2015 |
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
Topics: Adult; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver; Models, Biological; Pregnancy; Ritonavir; Young Adult | 2016 |
[Darunavir in special situations].
Topics: Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver; Male; Pregnancy; Pregnancy Complications, Infectious; Ritonavir | 2016 |
Successful rescue therapy with a darunavir/ritonavir and etravirine antiretroviral regimen in a child with vertically acquired multidrug-resistant HIV-1.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides; Treatment Outcome; Viral Load | 2008 |
Use of darunavir and enfuvirtide in a pregnant woman.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Peptide Fragments; Pregnancy; Pregnancy Outcome; Sulfonamides; Treatment Outcome; Viral Load | 2008 |
Transplacental passage of ritonavir-boosted darunavir in two pregnant women.
Topics: Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Sulfonamides | 2009 |
Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.
Topics: Darunavir; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Sulfonamides; Treatment Outcome | 2009 |
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.
Topics: Darunavir; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; RNA, Viral; Sulfonamides; Young Adult | 2010 |
Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.
Topics: Adult; CD4 Lymphocyte Count; Darunavir; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Sulfonamides; Treatment Outcome; Viral Load | 2010 |
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases.
Topics: Adolescent; Adult; Anti-HIV Agents; Darunavir; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Sulfonamides; Treatment Outcome; Young Adult | 2010 |